Shiba Inu (SHIB) Explodes 65% Daily, Dogecoin (DOGE) Follows Suit With 20% Surge (Weekend Watch)
The two-largest meme coins have taken the main stage in the crypto market in terms of daily gains.
Bitcoin’s price has calmed at around the $62,000 level after a noteworthy week in which the asset soared by over ten grand.
However, the altcoins have resumed their bull run with massive gains from the likes of DOGE, SHIB, BCH, UNI, ADA, and others
Altseason Incoming?
Numerous reports emerged in the past week or so suggesting that the altcoins, which were outperformed by Bitcoin lately, could be on the verge of a price explosion, thus triggering the next altseason. This prediction has materialized over the past 24 hours, at least for some.
Cardano, Polkadot, Chainlink, Polygon, Litecoin, and Ripple are just some of the examples of alts charting impressive gains. In their case, the daily increases are somewhere between 6-10%.
Even more impressive price pumps come from the two largest meme coins. DOGE has soared by 20% and sits close to $0.15, while SHIB has exploded by almost 70% and trades above $0.000021.
Bitcoin Cash is another notable gainer, having added more than 25% of value. As a result, BCH now trades close to $400. UNI and ETC have also jumped by double digits from the larger-cap alts.
Thus, the alternative coins have managed to reduce BTC’s dominance over them. The metric, which has soared by 5% in days to a two-month peak of nearly 51%, is now down to under 50% on CoinGecko.
The total crypto market cap remains close to $2.5 trillion.
Bitcoin Stops at $62K
The primary cryptocurrency had a big week as well. It all started on Monday after a quiet weekend in which the asset had remained stuck at $51,000. The bulls took charge and initiated a whooping leg-up that pushed BTC north by several thousand dollars.
By Tuesday and Wednesday, Bitcoin was knocking on the $60,000 door. After a brief hiatus there, it flew past that line and soared to a 26-month high of $64,000 later on Wednesday.
This is where the cryptocurrency faced a violent rejection that drove it south by more than five grand. Nevertheless, it managed to recover most of its losses almost immediately. Since then, BTC has stalled a bit and now stands at around $62,000.
Despite the declining market dominance, BTC’s market cap has remained at well above $1.2 trillion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Crypto prices
More
